Advertisement
U.S. markets open in 4 hours 56 minutes

Hemp, Inc (HEMP)

Other OTC - Other OTC Delayed Price. Currency in USD
0.00010.0000 (0.00%)
At close: 03:51PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0001
Open0.0002
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0001 - 0.0002
52 Week Range0.0001 - 0.0003
Volume5,345,092
Avg. Volume20,240,800
Market Cap1.766M
Beta (5Y Monthly)4.68
PE Ratio (TTM)N/A
EPS (TTM)-0.0020
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for HEMP

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • HEMP INC
    Weekly Stock ListWe see what we believe are some great opportunities right now in Healthcare -- and we like the sector overall. Argus Director of Research Jim Kelleher, CFA, recently completed his quarterly sector review and raised Healthcare sector to Over-Weight from Market-Weight. The healthcare environment is undergoing rapid transitions, and we now see an unfolding period of significant promise and opportunity. Our newly-favored stance is based on resumption of deferred medical procedures and significant new quality-of-life drugs and treatments. The category is broad and has underperformed the S&P 500 over the past year. The Healthcare sector ETF (XLV) is up 15% over the past year compared to a gain of 31% for the S&P 500. We see opportunity here to pick up some steady companies, with big brands and solid financials. These companies are science-focused and enhance lives. They are innovators. In our list this week, we look across several subsectors within the Healthcare sector and pull out some leaders we like. These stocks also are included in our Focus List and Model Portfolios, as noted below.
    Rating
    Fair Value
    Economic Moat
    21 hours agoArgus Research
View more
  • GlobeNewswire

    Hemp, Inc. Reports: Hemp-Based Foods Market Set to Reach $8.36 Billion by 2028

    LAS VEGAS, NV, Feb. 22, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire - Romaine calm! Hemp, Inc. (OTC:HEMP) is to report that the global hemp-based foods market is showing strong indicators of growth, fueled by the rising vegan population, advancements in processing technology, and the increasing number of health-conscious consumers seeking plant-based and gluten-free alternatives. The hemp-based foods market is set to reach $8.36 billion by 2028 according to The Business Research Company’s (TBRC) l

  • NewMediaWire

    Hemp, Inc. Profiled in Latest Global Report

    LAS VEGAS, NV - (NewMediaWire) - February 13, 2024 - Hemp, Inc. (OTC:HEMP) was profiled in a new report published by Allied Market Research, titled, "Industrial Hemp Market by Type, Application, and Source: Opportunity Analysis and Industry Forecast,...

  • GlobeNewswire

    Hemp, Inc. Drops the Skinny on the CBD Holiday Buzz

    LAS VEGAS, NV, Dec. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - This holiday season has been abuzz with everything from hemp-derived personal care products to CBD-infused food and beverages, Hemp, Inc. (OTC: HEMP) reports. Consumers can’t seem to get enough of the power-packed skinny foliage in personal care products, cosmetics, food, beverages, nutraceuticals, and other products, so much so that the global CBD market’s valuation is anticipated to reach $19.67 billion by 2032 and the Hemp So